Patents Assigned to Calregen Inc.
  • Publication number: 20160354438
    Abstract: The invention relates to therapeutic and cosmetic uses of calreticulin including reducing or eliminating wrinkles and/or fine lines, tissue repair and reconstruction, repairing damaged bone and/or cartilage, stimulating regeneration of an epidermal appendage, enhancing phagocytosis of bacteria by phagocytes within a wound, treating a wound in a patient suffering from delayed wound healing, treating a corneal wound, and treating or preventing a surgical adhesion.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 8, 2016
    Applicants: NEW YORK UNIVERSITY, CALREGEN INC.
    Inventors: Leslie I. GOLD, Marek MICHALAK
  • Publication number: 20160310563
    Abstract: The present invention relates to a method of treating chronic wounds using calreticulin. In particular, the invention relates to the treatment of chronic diabetic wounds using topical application of calreticulin to a patient in need of such treatment.
    Type: Application
    Filed: July 22, 2015
    Publication date: October 27, 2016
    Applicants: NEW YORK UNIVERSITY, CALREGEN INC.
    Inventors: Leslie I. GOLD, Marek MICHALAK
  • Patent number: 9254310
    Abstract: The invention relates to therapeutic and cosmetic uses of calreticulin including reducing or eliminating wrinkles and/or fine lines, tissue repair and reconstruction, repairing damaged bone and/or cartilage, stimulating regeneration of an epidermal appendage, enhancing phagocytosis of bacteria by phagocytes within a wound, treating a wound in a patient suffering from delayed wound healing, treating a corneal wound, and treating or preventing a surgical adhesion.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: February 9, 2016
    Assignees: NEW YORK UNIVERSITY, CALREGEN INC.
    Inventors: Leslie I. Gold, Marek Michalak
  • Patent number: 9095550
    Abstract: The present invention relates to a method of treating chronic wounds using calreticulin. In particular, the invention relates to the treatment of chronic diabetic wounds using topical application of calreticulin to a patient in need of such treatment.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: August 4, 2015
    Assignees: NEW YORK UNIVERSITY, CALREGEN INC.
    Inventors: Leslie I. Gold, Marek Michalak
  • Publication number: 20130150285
    Abstract: Therapeutic and cosmetic uses and applications of calreticulin are provided. In particular, the invention relates to therapeutic and cosmetic uses and applications of calreticulin to a patient in need of such treatment including in tissue repair, wound healing, ulcers, reducing scar formation, and reducing or eliminating wrinkles.
    Type: Application
    Filed: June 17, 2011
    Publication date: June 13, 2013
    Applicants: CALREGEN INC., NEW YORK UNIVERSITY
    Inventors: Leslie I. Gold, Marek Michalak
  • Publication number: 20130045918
    Abstract: The present invention relates to a method of treating chronic wounds using calreticulin. In particular, the invention relates to the treatment of chronic diabetic wounds using topical application of calreticulin to a patient in need of such treatment.
    Type: Application
    Filed: February 6, 2012
    Publication date: February 21, 2013
    Applicants: CALREGEN INC., NEW YORK UNIVERSITY
    Inventors: Leslie I. Gold, Marek Michalak
  • Patent number: 8129341
    Abstract: The present invention relates to a method of treating chronic wounds using calreticulin. In particular, the invention relates to the treatment of chronic diabetic wounds using topical application of calreticulin to a patient in need of such treatment.
    Type: Grant
    Filed: August 25, 2009
    Date of Patent: March 6, 2012
    Assignees: New York University, Calregen Inc.
    Inventors: Leslie I. Gold, Marek Michalak